Systemic antifungal agents used to treat onychomycosis.
Katz
H I
HI
Minnesota Clinical Study Center, Fridley 55432-3134, USA.
D000284:Administration, Oral; D000935:Antifungal Agents / Q000009:adverse effects / Q000627:therapeutic use*; D003883:Arthrodermataceae / Q000187:drug effects; D002175:Candida / Q000187:drug effects; D006801:Humans; D017964:Itraconazole / Q000009:adverse effects / Q000627:therapeutic use*; D009281:Naphthalenes / Q000009:adverse effects / Q000627:therapeutic use*; D014009:Onychomycosis / Q000188:drug therapy* / Q000382:microbiology; D000077291:Terbinafine; D016896:Treatment Outcome
D000935:Antifungal Agents; D009281:Naphthalenes; D017964:Itraconazole; D000077291:Terbinafine